Skip to main content
TipRanks
Go Ultimate75% OFF

Matex International Limited (M15) AI Stock Analysis

0 Followers
SG:M15

Matex International Limited

(SGX:M15)

Select Model
Rating:38Underperform
Price Target:SGD 0.02â–¼(-4.55% Downside)
Action:downgraded
Date:09/24/26

The overall score is critically low, driven primarily by a dire financial situation. The company is deeply unprofitable with collapsing margins, rapidly eroding equity, and a severe cash burn that threatens its viability. Technicals confirm a complete absence of investor interest, and the negative P/E ratio underscores the lack of earnings. The sole positive, TTM revenue growth, is entirely overshadowed by the company's inability to convert sales into profit or cash.

Positive Factors
Revenue RecoveryThe sharp TTM revenue rebound indicates renewed commercial activity and demonstrates that the company still has demand for its products. If maintained, stronger sales can improve operating leverage and provide a foundation for restoring profitability over the next several quarters.
Negative Factors
Deep UnprofitabilitySevere operating and net losses show that the recent revenue rebound has not translated into an economically sustainable business model. Persistently negative margins can erode equity, restrict reinvestment, and make future growth less valuable unless costs and pricing improve materially.

Matex International Limited (M15) vs. iShares MSCI Singapore ETF (EWS)

-5%0%5%10%15%20%25%30%SG:M150.00%EWS+6.71%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SGD 11.35M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-1.3
Beta (1Y)
0.09
Revenue Growth
25.81%
EPS Growth
-30.34%
Country
Singapore
Employees
65
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Matex International Limited Business Overview & Revenue Model

Company Description

Matex International Limited, headquartered in Singapore since its establishment in 1989, specializes in the development, production, and distribution of a diverse range of specialized chemical compounds. The company's operations extend across Singapo...

Matex International Limited Financial Statement Overview

Summary

Financial health is critically weak. TTM revenue grew 36% to $11.4M, but gross margins collapsed to 14%, leading to a -78% net margin and a $9.0M loss. Equity has halved to $4.9M, pushing the debt-to-equity ratio to 1.17x. Operating cash flow is deeply negative at -$6.3M, indicating a severe cash burn and liquidity crisis.

Income Statement

18Very Negative

Balance Sheet

22Negative

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue11.44M5.86M7.00M7.35M14.59M20.93M
Gross Profit1.60M865.00K1.47M1.61M2.51M2.64M
EBITDA-5.96M-6.51M-2.55M-3.23M5.39M-5.01M
Net Income-8.97M-6.77M-2.65M-3.31M7.27M-4.93M
Balance Sheet
Total Assets14.67M11.85M15.24M21.40M24.25M30.22M
Cash, Cash Equivalents and Short-Term Investments9.45M8.36M8.86M16.37M11.92M5.66M
Total Debt5.68M1.87M1.49M3.20M4.40M6.12M
Total Liabilities11.93M7.82M7.29M9.15M9.15M23.14M
Stockholders Equity4.85M6.05M9.05M12.70M14.88M7.80M
Cash Flow
Free Cash Flow-6.57M-5.28M-2.97M-754.00K-1.25M-35.00K
Operating Cash Flow-6.32M-5.19M-2.40M-456.00K-1.17M238.00K
Investing Cash Flow139.50K171.00K-3.23M3.82M11.77M-267.00K
Financing Cash Flow4.88M4.72M-1.88M1.12M-4.82M1.91M

Matex International Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

SG:M15 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SG:QESSG:QES72OutperformSGD 601.71M7.459.08%5.08%4.17%-12.40%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
SG:C05SG:C0559NeutralSGD 35.31M22.251.49%1.08%-7.25%95.72%
SG:M15SG:M1538UnderperformSGD 11.35M-1.30-164.44%―25.81%-30.34%
SG:C8RSG:C8R37UnderperformSGD 25.85M-0.56-48.10%―-69.91%-13.56%
SG:5WVSG:5WV35UnderperformSGD 10.36M-8.75-81.29%―――

* Basic Materials Sector Average

Performance Comparison

-40%-20%0%20%SG:M15SG:QESSG:C05SG:5DSSG:5WVSG:C8RDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SG:M15 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SG:M15Matex International Limited0.020.000.00%
SG:QESChina Sunsine Chemical Holdings Ltd.0.62-0.13-17.55%
SG:C05Chemical Industries Far East Ltd.0.47-0.11-19.13%
SG:5DSMegaChem Ltd.0.450.000.00%
SG:5WVAsiaPhos Limited0.010.000.00%
SG:C8RJiutian Chemical Group Limited0.01-0.01-51.85%

Matex International Limited Corporate Events

Nanyang New Development strengthens board independence with new director appointment

Jul 24, 2026

Nanyang New Development Limited has appointed Ms. Sim Kai Li as an independent director effective 25 July 2026, reinforcing its board independence in line with Catalist listing requirements. She will serve as chair of the Nominating Committee and joi...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 24, 2026